1-3 of 3
Joel Bowen
Close
Sort by
Journal Articles

Cardiovascular Disease Prevention in Persons with Hemophilia

Brandon Hardesty, Joel Bowen, Suman L Sood, Craig M. Kessler, Maissaa Janbain, Miguel Escobar, Doris V. Quon
Journal: Blood
Blood (2022) 140 (Supplement 1): 10777–10778.
https://doi.org/10.1182/blood-2022-163807
Published: 2022
Journal Articles

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Bagirath Gangadharan, PhD, Birgit Reipert, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karin Fijn van Draat, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, Margaret V. Ragni, MD MPH, Hassan M. Yaish, MD, Amy D. Shapiro, MD, Donald L Yee, MD, Vlad Calin Radulescu, MD, Elena Santagostino, Deborah Brown, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 88.
https://doi.org/10.1182/blood.V130.Suppl_1.88.88
Published: 2017
Journal Articles

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Birgit M Reipert, PhD, Bagirath Gangadharan, PhD, Christoph J Hofbauer, PhD, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karen Fijvandraat, MD, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, M V Ragni, MD, Hassan M Yaish, Elena Santagostino, MD PhD, Deborah L Brown, MD
Journal: Blood
Blood (2016) 128 (22): 328.
https://doi.org/10.1182/blood.V128.22.328.328
Published: 2016